Quorum Innovations, LLC is a specialty biopharmaceutical company at the forefront of microbiome therapeutics. With an aim to transform our understanding of healthcare, Quorum is dedicated to developing and delivering innovative biotherapeutics to physicians and their patients. Founded in 2010, the company is focused on harnessing the power of the human microbiome to develop therapies for common diseases and those with significant unmet medical needs.

Quorum's proprietary drug discovery platform, MINE (Microbiome Isolates and Novel Extracts), allows them to identify biotherapeutic candidates known as Quorum Probiomics™. These candidates are human microbiome immunomodulators that stimulate the innate immune response. By restoring critical organ barrier function and normal microbiome ecology, Quorum Probiomics™ has shown promise in chronic inflammatory skin diseases, gastrointestinal diseases, systemic metabolic disorders, and even oncology applications.

As leaders in the field, Quorum Innovations welcomes strategic partners interested in exploring innovative approaches to diseases in these areas. Together, they can further advance the discovery and development of novel human microbiome biotherapeutics. Embrace the future of healthcare with Quorum Innovations